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1. Introduction 
Rheumatoid arthritis is an autoimmune disorder in which there is joint inflammation, synovial proliferation and 
destruction of articular cartilage and bone. Extra-articular features commonly include general malaise, fatigue, weight loss, 
fever and anemia. The need of treatment is to reduce pain and improve function. Drugs used in this therapy are NSAIDs, 
corticosteroids, TNF, IL-1 inhibitors and DMARDs i.e. disease modifying anti rheumatic drugs. NSAIDS like Mefenamic 
acid, Ibuprofen, Diclofenac sodium, Ketoprofen, naproxen etc. are used for the treatment. Nanoparticulation is a very useful 
strategy towards targeted drug delivery. Particulate systems like nanoparticles have been used as a physical approach to 
alter and improve the pharmacokinetic and pharmacodynamic properties of various types of drug molecules. The present 
conventional drug delivery systems often have side-effects and complication due to their wide distribution throughout the 
body fluids. The localization of drug action in injured tissue is promising way to solve this problem. Various polymers have 
been used in the formulation of nanoparticles for drug delivery research to increase therapeutic benefit, while minimizing 
side effects.
 
[1,2] Chitosan is a natural polymer having excellent biodegradable properties. Methods for preparation of 
polymeric nanoparticles have been reviewed and they include ionic gelation, Co-acervation, solvent evaporation, 
spontaneous emulsification or solvent diffusion, salting out/emulsification-diffusion, supercritical fluid technology and 
polymerization. [4]  
Abstract 
Aim: Non steroidal anti inflammatory drugs are generally used as first line 
drugs for Rheumatoid arthritis. Mefenamic acid is an anthranilic acid 
derivative. The short biological half life of Mefenamic acid is 2hr. The aim of 
this investigation was to develop and characterize polymeric nanoparticles of 
Mefenamic acid by ionotropic gelation technique.  
Materials and methods: For ionic gelation technique, Chitosan was used as 
polymer and sodium tripolyphosphate as cross linking agent. All formulations 
were prepared by varying the drug and polymer concentrations. The obtained 
nanoparticles were characterized for surface morphology, FTIR, particle size 
and zeta potential and evaluated for yield, drug content, entrapment efficiency, 
loading capacity and Invitro drug release.  
Results and discussion: The mean particle size and zeta potential of the best 
formulation of Mefenamic acid nanoparticles for ionic gelation technique was 
found to be 196nm and -34 mV respectively. The drug release was found to be 
96.3% till 11hrs with fickian diffusion.  
Conclusions: Inotropic gelation technique was found to be the best technique 
for the formulation of Mefenamic acid nanoparticles as they have less particle 
size, greater stability and controlled drug release for 12hrs. 
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Ionic gelation is based on the ability of polyelectrolyte to cross link in the presence of counter ions. [5,6]
 
Mefenamic acid is a NSAID which is an anthranilic acid derivative.
 
[7] It is available as tablets, capsules and suspensions. 
The available dose for this drug is 250mg thrice a day. MA has a wide range of gastrointestinal disorders, like 
gastrointestinal bleeding and gastric upset.[8]
 
MA is classified as class II on the basis of biopharmaceutical classification 
system, because of its poor solubility over the pH range 1.2-7.5. [9] The short biological half life of MA is 2hr. Because of 
short half life, frequent administration of the drug is required to maintain the desired steady state level, hence nanoparticles 
are formulated to achieve sustained release properties. [10] In the present study, Mefenamic acid nanoparticles were 
formulated using ionotropic gelation techniques. 
 
2. Materials and Methods 
2.1 Materials 
Mefenamic acid was purchased from Sigma Aldrich, Bangalore and chitosan from Himedia. 
2.2 Methods 
2.2.1 Ionotropic Gelation Technique for Preparation of Mefenamic Acid Nanoparticles 
In order to obtain nano formulations, process parameters were optimized which include concentration of cross 
linking agent, stirring speed, stirring time. Mefenamic acid loaded chitosan nanoparticles were prepared using ionotropic 
gelation technique. Chitosan solutions of 0.25%, 0.35 and 0.4% were prepared by using 0.1% acetic acid solution. The drug 
was dissolved in the polymer solution. It was added drop wise into 0.5% TPP solution which was kept under magnetic 
stirring at 700 rpm for 5hrs.The fine dispersion was collected and centrifuged using ultra centrifuge at 10000 rpm for 
15min.The pellet was collected and dried. The same procedure was followed for other ratios. 
Five formulations were prepared.F1, F2 and F3 formulations were prepared by varying the concentrations of 
chitosan in the range of 0.25%, 0.35% and 0.4%.F1, F4 and F5 formulations were prepared by changing the concentration 
of drug (1:1, 1.5:1, 2:1) 
2.2.2 Characterization of the nanoparticles  
Particle size measurement 
It is done by Nano Partica analyzer (HORIBA SZ-100 series).Dynamic Light Scattering (DLS), also known as 
Photon Correlation Spectroscopy, is a common technique for measuring the size of particles in the sub micron range. 
Zeta potential: 
The zeta potential is a physical property which is exhibited by all particles in suspension. It is an important 
parameter in understanding the electric double layer repulsion and it can be measured by phase analysis light scattering.  
Scanning electron microscopy  
Scanning electron microscopy (SEM) is based on the incidence of a beam of accelerated electrons on the sample. 
These accelerated electrons interact with the sample, exciting its atoms which emit secondary electrons. According to the 
angle between the primary beam and the surface of the sample, it is possible to detect and analyze the surface topography.  
Fourier Transforms infrared Spectroscopy (FT-IR): 
The FT-IR spectra acquired were taken for the dried samples. An FT-IR (7000) spectrometer was used for the 
analysis in the frequency range between 4000 and 400 cms
-1
. 
2.3 Evaluation of nanoparticles
  
Determination of Drug content in Nanoparticle sample: 
Free drug of the formulations was first determined in the supernatant by choosing a solvent in which only the free 
drug gets dissolved and not the other ingredients. To determine the drug content, 50mg drug equivalent to formulation was 
weighed accurately and transferred into three necked RBF containing 50ml of methanol. The solution was stirred at 700rpm 
for 3hrs using magnetic stirrer. The resultant solution was filtered and the amount of the drug in the filtrate was estimated 
after suitable dilution by ultraviolet (UV) spectrophotometer at 285nm.  
Entrapment efficiency 
Entrapment efficiency indicates the amount of drug encapsulated in the formulation. The method of choice for 
drug content determination is separation of free drug by ultra centrifugation, followed by quantitative analysis of the drug 
from the formulation. The samples were centrifuged using ultracentrifuge at 17640 rpm for 40min. 
Percentage entrapment efficiency may be calculated from the following formula: 
 
  𝐸𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 =  
𝐴𝑚𝑜𝑢𝑛𝑡  𝑜𝑓  𝑑𝑟𝑢𝑔  𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑  𝑖𝑛  𝑡ℎ𝑒 𝑓𝑜𝑟𝑚𝑢𝑙𝑎𝑡𝑖𝑜𝑛
𝑇𝑜𝑡𝑎𝑙  𝑎𝑚𝑜𝑢𝑛𝑡  𝑜𝑓  𝑑𝑟𝑢𝑔  𝑖𝑛  𝑡ℎ𝑒  𝑓𝑜𝑟𝑚𝑢𝑙𝑎𝑡𝑖𝑜𝑛
  ×  100 
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Loading Capacity 
The loading capacity (L.C) refers to the polymer carrying capacity of the drug. 
Loading capacity = 
𝑇𝑜𝑡𝑎𝑙  𝑎𝑚𝑜𝑢𝑛𝑡  𝑜𝑓  𝑑𝑟𝑢𝑔 −𝐴𝑚𝑜𝑢𝑛𝑡  𝑜𝑓  𝑢𝑛𝑏𝑜𝑢𝑛𝑑  𝑑𝑟𝑢𝑔
𝑁𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠  𝑤𝑒𝑖𝑔 ℎ𝑡
× 100 
Percentage Yield:  
The yields of the prepared nanoparticles were calculated. The dried nanoparticles were weighed and the yield of 
nanoparticles was calculated using the formula: 
      Percentage yield   =   
𝐴𝑚𝑜𝑢𝑛𝑡  𝑜𝑓  𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠  𝑜𝑏𝑡𝑎𝑖𝑛𝑒𝑑
𝑇ℎ𝑒𝑜𝑟𝑒 𝑡𝑖𝑐𝑎𝑙  𝑎𝑚𝑜𝑢𝑛𝑡
× 100 
Drug release studies: 
 Drug release studies were performed by means of Orbitary shaker. Drug release from polymeric nanoparticles was 
determined as follows. A known amount of nanoparticles was transferred to a conical flask and 50mL of the Phosphate 
buffer pH 7.4 was added to the conical flask. The temperature and rotation were adjusted to 37°C and 100 rpm, 
respectively. 5ml aliquots were drawn at 0.5, 2, 4, 6, 8, 10, 12, and 24 hrs and it was replaced by the 5ml of fresh medium. 
The samples were centrifuged at 3000 rpm for 15 minutes. The samples were further analyzed using UV Spectrophotometer 
at 285 nm. 
 
3. Results  
3.1 Ionotropic gelation technique for Mefenamic acid (MA) loaded chitosan (CH) nanoparticles. 
Mefenamic acid loaded chitosan nanoparticles were prepared by ionotropic gelation technique. In order to obtain 
nanoformulations, the process parameters such as concentration of cross linking agent, stirring speed, stirring time were 
optimized. Five formulations were prepared by varying the drug and polymer concentrations. The prepared five 
formulations were characterized and evaluated. 
3.2 Scanning electron microscopy of Mefenamic acid (MA) loaded chitosan (CH) nanoparticles by ionotropic 
gelation technique. 
The surface morphology of the nanoparticles was determined by using scanning electron microscopy. All 
formulations were found to be spherical in shape and were in nanorange.[ Figure 1] 
 
Figure 1:- SEM Images of Mefenamic acid (MA) loaded chitosan (CH) nanoparticles 
Mean particle diameters  
The mean particle diameters of F1, F2, F3, F4 and F5 formulations were found to be in the range of 148-
210nm.Particle size distribution report of F2 formulation was depicted in Figure 2. Comparision of mean particle diameters 
of al five formulations was given in figure 3. 
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Figure 2: Particle size distribution report of F2 formulation of CH MANPs. 
 
Figure 3:- Comparison of mean particle diameters of mefenamic acid loaded chitosan F2 formulation 
Zeta potential values  
The zeta potential values of F1, F2, F3, F4, and F5 formulations were found to be in the range of 30-48mV 
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[Figure 4]. The arbitrary zeta potential value is ± 30 mV. So, all formulations were found to be stable. 
 
Figure 4:- Comparison of zeta potential values of mefenamic acid loaded chitosan formulations 
Comparison of Product yields  
The product yields of all five formulations were found to be 93.5%, 94.4%, 90.3%, 92.3% and 94%. It is depicted 
in [Figure 5]. Among all the formulations, F2 was considered to have higher yield. 
 
Figure 5: Comparison of product yields of F1, F2, F3, F4, F5 formulations of CH MANPs. 
Comparison of Drug contents / 
The drug contents of all five formulations were found to be 84.5%, 94.2%, 93.5%, 90% and 91.1%. It is depicted 
in Figure 6. Among the, F2 showed higher drug content. 
 
Figure 6: Comparison of drug contents of F1, F2, F3, F4, and F5 formulations of CH MANPs. 
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Comparison of Entrapment efficiencies 
The entrapment efficiencies of F1, F2, F3, F4 and F5 formulations were found to be 61%, 84%, 80%, 81% and 
82.3%. F2 has greater entrapment efficiency than the other formulations (shown in Figure 7. 
 
Figure 7: Comparison of entrapment efficiencies of F1, F2, F3, F4, F5 formulations of CH MANPs. 
 
Comparison of loading capacities 
The loading capacities of F1, F2, F3, F4 and F5 formulations were found to be 39.6%, 36.4%, 27.9%, 52% and 
54.2%. Loading capacity of F5 formulation was more when compared with other formulations. [Figure 8] 
 
Figure 8:- Comparison of loading capacities of F1, F2, F3, F4, F5 formulations of CH MANPs. 
 
In vitro drug release studies  
The drug release studies were performed for 24hrs.The percentage of drug release from F4 and F5 was found to be 
94.6% and 96.8% respectively with in a time period of 6hrs. From F2 formulation the percentage of drug release was found 
to be 96.3% in 12 hr and F3 formulation was able to control up to 10hrs with 97.6% of drug release. Among all the 
formulations, F2 was found to be the best formulation as it controlled drug release up to 12hrs with 96.3% drug release. In 
F1, F3, F4and F5 formulations, the polymer concentration was not sufficient to retard the drug release. Comparative drug 
release profile was given in figure 9. 
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Figure 9:-Comparative drug release studies of CH formulations 
 
The drug release data of F2 formulation was fitted into various kinetic plots in order to determine the mechanism 
and order of release. 
 
Figure 10:- Zero order plot of F2 formulation of CH MANPs 
 
 
Figure 11:- First order plot of F2 formulation of CH MANPs 
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Figure 12:- Higuchi plot of F2 formulation of CH MANPs 
 
 
Figure 13:  Peppas plot of F2 formulation of CH MANPs 
 
The curve fitting data revealed that the release followed First order kinetics and Higuchi and Peppas plots, stated 
Fickian diffusion controlled in all the formulations. 
 
4. Discussion 
  Mefenamic acid polymeric nanoparticles (MANPs) were formulated by solvent evaporation and ionotropic 
gelation techniques using Eudragit S-100, Ethyl cellulose and Chitosan polymers. 
For ionotropic gelation technique, a natural polymer such as chitosan was selected for the study. Chitosan is a 
biocompatible, biodegradable and natural polymer. Here the process parameters including stirring speed, concentration of 
cross linking agent and stirring time were optimized. Five formulations were prepared by varying the drug and polymer 
concentrations. Nanoparticles prepared by ionic gelation method using chitosan as polymer and sodium tripolyphosphate as 
cross linking agent produced particles of good stability. [17,18] It seems that the relatively lower viscosity of chitosan with 
a concentration as low as 0.35% and an appropriate concentration of TPP (0.5 %w/v) promoted the formation of 
nanoparticles.[19] All formulations were in nano range and found to be spherical with optimum stability. The mean particle 
diameter of F1 was found to be less as the drug and polymer proportions are equal. The zeta potential of the F1 formulation 
was found to be more because of the minimum mean diameter. The polymer appeared to have good compatibility with the 
entrapped Mefenamic acid as there was no clear evidence of interaction between the two compounds. Among five 
formulations, In vitro drug release data of F2 formulation showed 96.3% of drug release sustained up to 11hrs. Entrapment 
of the drug within the gel network of the chitosan matrix may have made the formulation more stable.
 
[20] Though F1 
formulation has got minimum diameter and higher stability, F2 was considered to be the best based on the entrapment 
efficiency and sustained release properties.  
International Journal of Advances in Pharmaceutics 5 (6) 2016                                                                                 159 
 
 
5. Conclusions 
MANPs were formulated by solvent evaporation and ionotropic gelation techniques. Comparative study was done 
between the polymers of solvent evaporation technique and also between  the techniques.F3 of ED was found to be the best 
formulation for the preparation of MANPs  with particle diameter of 103.6nm, greater stability(59.5mV) and higher 
entrapment efficiency(85.7%) and 98.2% of drug release in 12hrs. 
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